Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Halting Nucleoside Analogues in Chronic Hepatitis B (HALT-NUCS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04102176
Recruitment Status : Recruiting
First Posted : September 25, 2019
Last Update Posted : September 26, 2019
Sponsor:
Collaborators:
Tan Tock Seng Hospital
Singapore General Hospital
Changi General Hospital
Information provided by (Responsible Party):
Seng Gee Lim, National University Health System, Singapore

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 2021
Estimated Study Completion Date : March 30, 2021